Skip to content

The effect of portal vein embolisation on portal venous perfusion of the liver

The effect of portal vein embolisation on portal venous perfusion of the liver - Effect of PVE on liver perfusion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34722
Enrollment
45
Registered
2011-03-07
Start date
2010-08-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary or secondary liver tumor.

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patient is planned for elective liver resection or PVE is performed, and patient will undergo hepatic surgery within 3-6 weeks after PVE 2. Age * 18 years 3. Signed written informed consent obtained prior to any study-specific procedure 4. ASA classification I * IV

Exclusion criteria

Exclusion criteria: 1. Age

Design outcomes

Primary

MeasureTime frame
The primary endpoint is defined as the effect of PVE on portal venous perfusion of the liver.

Secondary

MeasureTime frame
Secondary study parameters/endpoints are: * the parameters obtained using the O2C technique; * the hepatic I/R injury after vascular clamping; * the perfusion of the liver on microvascular level; and * liver regeneration after PVE and surgery.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)